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Oxygen-dependent ATF-4 stability is mediated by the PHD3
oxygen sensor
Abstract
The activating transcription factor-4 (ATF-4) is translationally induced under anoxic conditions,
mediates part of the unfolded protein response following endoplasmic reticulum (ER) stress, and is a
critical regulator of cell fate. Here, we identified the zipper II domain of ATF-4 to interact with the
oxygen sensor prolyl-4-hydroxylase domain 3 (PHD3). The PHD inhibitors dimethyloxalylglycine
(DMOG) and hypoxia, or proteasomal inhibition, all induced ATF-4 protein levels. Hypoxic induction
of ATF-4 was due to increased protein stability, but was independent of the ubiquitin ligase von
Hippel-Lindau protein (pVHL). A novel oxygen-dependent degradation (ODD) domain was identified
adjacent to the zipper II domain. Mutations of 5 prolyl residues within this ODD domain or
siRNA-mediated down-regulation of PHD3, but not of PHD2, was sufficient to stabilize ATF-4 under
normoxic conditions. These data demonstrate that PHD-dependent oxygen-sensing recruits both the
hypoxia-inducible factor (HIF) and ATF-4 systems, and hence not only confers adaptive responses but
also cell fate decisions.
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The activating transcription factor-4
(ATF-4) is translationally induced under
anoxic conditions, mediates part of the
unfolded protein response following en-
doplasmic reticulum (ER) stress, and is
a critical regulator of cell fate. Here, we
identified the zipper II domain of ATF-4
to interact with the oxygen sensor prolyl-
4-hydroxylase domain 3 (PHD3). The
PHD inhibitors dimethyloxalylglycine
(DMOG) and hypoxia, or proteasomal
inhibition, all induced ATF-4 protein lev-
els. Hypoxic induction of ATF-4 was due
to increased protein stability, but was
independent of the ubiquitin ligase von
Hippel–Lindau protein (pVHL). A novel
oxygen-dependent degradation (ODD)
domain was identified adjacent to the
zipper II domain. Mutations of 5 prolyl
residues within this ODD domain or
siRNA-mediated down-regulation of
PHD3, but not of PHD2, was sufficient to
stabilize ATF-4 under normoxic condi-
tions. These data demonstrate that PHD-
dependent oxygen-sensing recruits both
the hypoxia-inducible factor (HIF) and
ATF-4 systems, and hence not only con-
fers adaptive responses but also cell
fate decisions. (Blood. 2007;110:
3610-3617)
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Introduction
When O2 delivery is impaired, the resulting hypoxia activates
homeostatic mechanisms at the systemic and cellular level.1 This
response involves changes in gene expression mediated by hypoxia-
inducible factor-1 (HIF-1), the master transcription factor of
oxygen-regulated genes. HIF-1 is a heterodimeric protein compris-
ing the oxygen-sensitive -subunit (HIF-1, or the more cell-type–
specifically expressed HIF-2) and the oxygen-insensitive -sub-
unit.2 Oxygen-regulated gene expression involves binding of HIF
to cis-regulatory hypoxia response elements (HREs) of HIF target
genes such as erythropoietin or vascular endothelial growth factor.3
The molecular basis for the hypoxia-induced stability and activity
of HIF-1 and HIF-2 is the O2-dependent hydroxylation of
distinct prolyl residues.4-6 A family of oxygen-, iron- and 2-oxoglu-
tarate-dependent prolyl-4-hydroxylases has been described re-
cently to hydroxylate the oxygen-labile  subunits of HIF-1 and
HIF-2.5,7,8 This family consists of 3 members called prolyl-4-
hydroxylase domain (PHD) 1, PHD2, PHD3, or HIF prolyl
hydroxylase (HPH) 3, HPH2, and HPH1, respectively.4,5 Following
prolyl-4-hydroxylation of the critical prolyl residues under nor-
moxic conditions, the ubiquitin ligase von Hippel–Lindau tumor
suppressor protein (pVHL) recognizes HIF subunits and targets
them for rapid ubiquitination and proteasomal degradation.9 Bind-
ing of pVHL strictly requires prior modification of human HIF-1
and HIF-2 by prolyl-4-hydroxylation at prolines 402 and 564 or
prolines 405 or 531, respectively.10,11 Limited oxygen supply
prevents HIF hydroxylation and degradation.12 In addition to
protein stability, oxygen-dependent C-terminal asparagine hydroxy-
lation of HIF by factor-inhibiting HIF (FIH) prevents transcrip-
tional cofactor recruitment, thereby fine-tuning HIF-1 activity after
a further decrease in oxygen availability.13 Most interestingly, in
addition to HIF, ankyrin repeats present in IB and NF-B family
members have recently been described to be hydroxylated by FIH,
demonstrating that hydroxylation is not restricted to the HIF
signaling pathway.14
Besides similarities in the hydroxylation reaction in vitro, the
3 PHDs differ in their ability to hydroxylate HIF-1 in vivo and in
their organ-specific expression pattern.15-17 Moreover, the pheno-
types of PHD knock-out mice demonstrate divergent roles of the
3 PHDs during embryonic development.18 These data indicate that
under physiologic conditions, PHD1, PHD2, and PHD3 mediate
different, probably even HIF-independent, oxygen-regulated signal
transduction pathways.
By searching for novel targets of PHD3 using yeast 2-hybrid
technology, we identified activating transcription factor-4 (ATF-4)
as a novel interaction partner, and we found that PHD3 confers
oxygen-dependent ATF-4 protein stability in a pVHL-independent
manner. ATF-4–deficient mice are severely anemic during fetal
development, apparently because of an impairment in definitive
hematopoiesis.19 In addition, overexpression of ATF-4 near ne-
crotic areas in tumor tissues has been described, suggesting a role
of ATF-4 in cancer.20 Since ATF-4 influences DNA repair as well as
cell fate decisions via its target genes like GADD153, the presented
data may help to understand the physiologic and pathophysiologic
role of ATF-4 for hematopoiesis, cancer physiology, and tumor
therapy resistance.20
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as Blood First Edition paper, August 7, 2007; DOI 10.1182/blood-
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Materials and methods
Plasmids
All cloning work was carried out using Gateway technology (Invitrogen,
Carlsbad, CA). Full-length ATF-4 was amplified by polymerase chain
reaction (PCR) from a HeLa cDNA pool. Full-length PHD1–3 was
amplified by PCR from plasmids pcDNA3.1PHD1 and pcDNA3.1PHD3
(kindly provided by F. Oehme and I. Flamme, Wuppertal, Germany), or
pcDNA3.1HA-PHD2 (kind gift from W. G. Kaelin Jr, Boston, MA).
Site-directed mutagenesis or deletion mutants were performed with the
ATF-4 entry vector using the QuickChange kit (Stratagene, La Jolla, CA).
To generate plasmids expressing fusion proteins, DNA inserts were
transferred from entry clones to destination vectors using LR Clonase
recombination enzyme mix (Invitrogen). To generate plasmids expressing
the Gal4-BD and the Gal4-AD fused to an oxygen-dependent degradation
(ODD) domain of interest, PCR-amplified DNA fragments were cloned into
the EcoRI-digested pM3VP16 (BD Clontech, Palo Alto, CA). The Gal4
containing luciferase reporter gene vector pGREx5E1bLuc was kindly
provided by D. Peet (University of Adelaide, Australia).
Yeast 2-hybrid analyis
Yeast 2-hybrid analyses were performed using the ProQuest 2-hybrid
system by following the manufacturer’s recommendations (Invitrogen).
Full-length PHD3 fused to the Gal4-BD was expressed from pDEST32-
PHD3 in Saccharomyces cerevisiae strain MaV203 (Invitrogen). To test for
self-activity, cotransformants of pDEST32-PHD3 and pExpAD502, encod-
ing the Gal4-AD, were tested on selection plates. A ProQuest human brain
cDNA library was transformed into MaV203 pDEST32-PHD3, and transfor-
mants were screened on synthetic drop-out medium lacking tryptophan,
leucine, and histidine, as well as 10 mM 3-amino-1,2,4-triazole (3-AT;
Sigma, St Louis, MO). Positive clones were further assayed for growth on
synthetic dropout medium lacking tryptophan, leucine, and uracil, and for
-galactosidase activity, to characterize the strength of the interaction. The
pExpAD502 plasmids encoding putative PHD3-interacting proteins were
isolated, retested for interaction, and checked for self-activity. Inserts of
confirmed interactors were sequenced to ensure in-frame coding sequence
with the activation domain of Gal4.
Protein analysis
Proteins were separated by SDS-PAGE and detected by immunoblotting.
Antibodies used were mouse anti–HIF-1 (Transduction Laboratories,
Franklin Lakes, NJ), rabbit anti–maltose-binding protein (MBP) (New
England Biolabs, Ipswich, MA), mouse anti–-actin (Sigma), mouse
anti-V5 (Invitrogen), rabbit anti–ATF-4 (Santa Cruz Biotechnology, Santa
Cruz, CA), rabbit anti-PHD2 (Abcam, Cambridge, United Kingdom), and
rabbit anti-PHD3 (Abcam). Immunocomplexes were detected by using
horseradish-conjugated goat anti-rabbit or goat anti-mouse antibodies
(Santa Cruz Biotechnology) and incubation of the membranes with 100 mM
Tris-HCl (pH 8.5), 2.65 mM H2O2, 0.45 mM lumin, and 0.625 mM
coumaric acid for 1 minute, followed by exposure to X-ray films (Amer-
sham, Arlington Heights, IL) or detection of the signal with the LAS3000
camera system (Fiji Film Europe, Du¨sseldorf, Germany).
Protein expression and purification
MBP fusion proteins were expressed in the Escherichia coli strain TB1
(New England Biolabs) transformed with pMal-c2x or derivatives and
purified using the MBP purification system according to the manufacturer’s
instructions (New England Biolabs). His-PHD3 was purified from insect
cells as described previously.21
In vitro pull-downs
Purified MBP–ATF-4 fusion protein (10 g) was bound in buffer 1 (20 mM
Tris-HCl [pH 7.5], and 200 mM NaCl) to bovine serum albumin (BSA)–
blocked amylose-resin (New England Biolabs) for 1 hour at 4°C. Bound
proteins were incubated with His-PHD3 in 500 L 10 mM Na-phosphate,
(pH 7.0), 5 mM MgCl2, 100 mM NaCl, 100 M FeSO4, and 0.1 mg/mL
BSA for 1 hour at 30°C. The resins were washed 5 times, and bound
proteins were eluted with SDS-PAGE loading buffer and subjected to
immunoblot analysis.
Cell culture
HeLa cells were cultured in high-glucose Dulbecco modified Eagle medium
containing 10% fetal calf serum, 50 U/mL penicillin G, and 50 g/mL
streptomycin (Invitrogen) in a humidified 5% CO2, 95% air atmosphere at
37°C. For hypoxic conditions, O2 levels were decreased to 0.2% or 1% O2
with N2 in an oxygen-controlled incubator (Binder, Tuttlingen, Germany).
TS-20 cells are derivatives of 3T3 fibroblasts, which harbor a temperature-
sensitive defect in the E1 ubiquitin–activating enzyme.22,23 H38–5 cells are
reconstituted with a wild-type allele of the E1 enzyme. Both cell lines were
kindly provided by C. Borner (Center for Biochemistry and Molecular Cell
Research, Freiburg, Germany). In some experiments, cells were treated
with 10 M MG132 (Alexis, Gru¨nberg, Germany), 1 mM DMOG (Frontier
Scientific, Carnforth, United Kingdom), 20 g/mL cycloheximide (Sigma),
or 300 nM thapsigargin (AppliChem, Darmstadt, Germany) for the
indicated time periods.
Transient transfection and luciferase assay
A total of 1 g pcDNA3.1Dest-V5-ATF-4 or various ATF-4 mutants were
transfected together with 0.2g pEGFPC1 by calcium phosphate coprecipi-
tation. For luciferase assays, HeLa cells were transfected with 250 ng firefly
luciferase reporter vector pATFx2-Luc, containing 2 cAMP response
element (CRE) sites (kind gift of T. Hai, Ohio State University, Columbus,
OH) or pH3SVL containing 3 HRE sites and 2.5 ng of pRLSV40, encoding
renilla luciferase, for internal standardization (Promega, Madison, WI). For
transient transfection of the Gal-4BD/Gal-4AD fusion proteins, 62 ng
pM3XVP16 was transfected along with 250 ng luciferase reporter vector
pGREx5E1bLuc. The total amount of plasmid DNA was adjusted to 1 g
by addition of empty pcDNA3.1 vector (Invitrogen).
Gene silencing by RNAi
The following stealth RNAi (Invitrogen) sequences were used: control siRNA,
forward 5-gcuccggagaacuaccagaguauua-3; control siRNA, reverse 5-uaauacu-
cugguaguucuccggagc-3; PHD2 siRNA, forward 5-ggacgaaagccaugguugcu-
uguua-3; PHD2 siRNA, reverse 5-uaacaagcaaccauggcuuucgucc-3; PHD3
siRNA, forward 5-gcuauccgggaaaugga-acagguua-3; and PHD3 siRNA, reverse
5-uaaccuguuccauuucccggauagc-3. HeLa cells were transfected with 80 nM
siRNAs using Lipofectamin 2000 (Invitrogen).
RNA extraction and real-time RT-PCR
After total RNA extraction, reverse transcription was performed with 1 g of
RNA (Fermentas) in a total volume of 20 L. Subsequently, mRNA expression
levels were quantified with 1 L of cDNA reaction by real-time PCR using a
SybrGreen Q-PCR reagent kit (Stratagene) in combination with the MX3000P
light cycler (Stratagene). Initial template concentrations of each sample were
calculated by comparison with serial dilutions of a calibrated standard. Primers
were as follows: PHD2 forward, 5-gaaagccatggttgcttgtt-3; PHD2 reverse,
5-ttgccttctggaaaaattcg-3; PHD3 forward, 5-atcgacaggctggtcctcta-3; PHD3
reverse, 5-cttggcatcccaattcttgt-3; ATF-4 forward, 5-tcaaacctcatgggttctcc-3;
ATF-4 reverse, 5-gtgtcatccaacgtggtcag-3; hL28 forward, 5-gcatctgcaatggatggt-
3; and hL28 reverse, 5-tgttcttgcggatcatgtgt-3.
Results
Identification of ATF-4 as a novel PHD-binding protein
To identify novel interaction partners of PHD3 by yeast 2-hybrid
analysis, we screened a human brain cDNA library fused to Gal4
activation domain (AD) with full-length PHD3 fused to Gal4
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binding domain (BD) as bait. As shown in Figure 1A, the PHD3
bait alone was unable to confer yeast growth. A total of 4 out of
69 prey clones were found to be independent AD fusions to the
cDNA of HIF-2, corresponding to amino acid (aa) 73-870 (Figure
1A), aa 379-870, aa 398-870, and aa 451-870 (data not shown). All
4 HIF-2 clones contain at least the C-terminal part of the ODD
domain (aa 404-569) which includes proline 531. This site is
known to be modified by PHD3, hence confirming the reliability of
our screen.
An additional 4 prey clones derived from this screen corre-
sponded to ATF-4 fusion proteins encompassing ATF-4 (National
Center for Biotechnology information data base24 accession num-
ber NM 001675) aa 27-351 (Figure 1A), aa 42-351, aa 51-351,
and aa 83-351 (data not shown). No other proteins of the
ATF/CREB family were identified in this screen. No protein-
protein interaction was found in further yeast 2-hybrid analyses
using PHD1, PHD2, or FIH fused to Gal4-BD together with
full-length ATF-4 fused to Gal4-AD (data not shown). ATF-4
comprises 2 zipper domains: a C-terminal basic leucine zipper as
well as a zipper II. Through its C-terminal basic leucine zipper
domain, it dimerizes with members of either the ATF/CREB family
or other basic leucine zipper transcription factor families like c-Fos
or c-Jun.25 The zipper II as the main PHD3-interaction domain was
verified by lack of interaction of the ATF-4 zipper II deletion
mutants (ATF-4 aa 89-125 and ATF-4 aa 89-181) with PHD3
(Figure 2).
The binding of full-length ATF-4 to PHD3 was shown in vitro
by MBP pull-down assays (Figure 1B). Likewise, ATF-4 tagged
with the V5-epitope synthesized in rabbit reticulocyte lysates
bound to a bacterially expressed MBP-PHD3 fusion protein (data
not shown). In contrast to the recently described WD-repeat protein
mitogen-activated protein kinase (MAPK) organizer (Morg)–1,
which affects HIF-1 most likely via modulation of PHD3 activity,26
ATF-4 did not influence PHD activity and thereby HIF stability/
activity, as determined by HIF-dependent reporter gene assays after
coexpression of HIF-2 and PHD3 (Figure 1C). We additionally
excluded an effect of ATF-4 on the HRE-driven luciferase activity
Figure 1. Interaction of ATF-4 with PHD3. (A) The
yeast reporter strain MaV203 expressing Gal4-BD-
PHD3 and Gal4-AD-ATF-4 aa 27–351 or Gal4-AD-
HIF2 aa 73–870 was assayed for histidine auxotrophy.
(B) His-PHD3 expressed in insect cells is captured by
immobilized MBP–ATF-4. Antibodies against MBP or
PHD3 were used for immunoblot detection as indicated.
(C) HeLa cells were cotransfected with a firefly lucif-
erase reporter gene plasmid driven by HREs together
with a constitutively expressed renilla luciferase control
vector as depicted and the expression plasmids
pcDNA3.1HIF-2, pcDNA3.1PHD3, or pcDNA3.1V5-
ATF-4. After 24 hours, HeLa cells were lysed and
analyzed for firefly (FL) and renilla luciferase (RL)
activities. (D) HeLa cells were cotransfected with an
HRE-driven firefly luciferase reporter gene plasmid and
a constitutively expressed renilla luciferase control vec-
tor as in panel C and the empty control vector pcDNA3.1
or the expression plasmid pcDNA3.1V5ATF-4. Subse-
quently, cells were incubated at 20% O2 or 1% O2 for
24 hours, lysed, and analyzed for firefly and renilla
luciferase activities (C,D). Shown are mean values of
the FL/RL ratios ( SD) of 3 independent experiments.
Figure 2. Mapping the PHD3 binding domain of ATF-4. (A) Schematic drawing of
the protein domains of ATF-4. Arrows (27, 42, 51, and 83) indicate the insertion of the
4 independent ATF-4 prey-clones identified by yeast 2-hybrid screening of the human
brain cDNA library with PHD3 as bait. (B) Yeast reporter strain MaV203 expressing
Gal4-BD-PHD3 and various domains of ATF-4 as Gal4-AD-fusions was assayed for
histidine and uracil auxotrophy. (C) Yeast reporter strain MaV203 expressing
Gal4-BD-PHD3 and various deletion variants of ATF-4 as Gal4-AD fusions was
assayed for histidine and uracil auxotrophy.
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by coexpressing ATF-4 together with the reporter gene plasmid at
20% or 1% oxygen. (Figure 1D).
Hypoxia and PHD inhibitors stabilize ATF-4
Previous reports have established a regulatory mechanism for
translational control of ATF-4 in response to endoplasmic reticu-
lum (ER) stress, amino acid starvation, and anoxia.27 Exposing
HeLa cells to the ER stress–inducing agent thapsigargin as well as
to the proteasome inhibitor MG132 both resulted in enhanced
ATF-4 levels (Figure 3A). To further confirm the involvement of
the ubiquitin-proteasome system in the degradation of ATF-4, the
temperature-sensitive E1 mutant cell line TS20 was cultured under
normoxic conditions at 34°C and 39°C. As demonstrated in Figure
3C, TS20 cells do not express ATF-4 at 34°C, whereas growing the
cells at 39°C resulted in accumulation of ATF-4. Simultaneous
exposure to 39°C of the E1-corrected cells H38–5 did not result in
increased ATF-4, suggesting that in addition to translation, ATF-4
might also be regulated on the level of protein degradation.
Interestingly, DMOG, which is able to induce HIF-1 via
inhibition of PHDs, also induced ATF-4 reporter gene activity,
further supporting the existence of an alternative ATF-4 induction
pathway (Figure 3B). If ATF-4 was regulated by PHD3, it should
be stabilized not only by DMOG but also by hypoxia. Thus, we
next determined ATF-dependent reporter gene activity using a
luciferase expression construct under the control of 2 CRE sites.
A strong increase in reporter gene activity was observed after
exposing transfected HeLa cells to 1% O2 (Figure 3B). Exposing
HeLa cells for 4 hours to 1% or 0.2% O2 enhanced the levels of
ATF-4 similar to HIF-1 (Figure 4A; compare lanes 3 and 5 with
lane 1). Inhibition of endogenous PHDs with DMOG was followed
by increased ATF-4 protein in normoxia (Figure 4A; compare lanes
1 and 2) and enhanced the hypoxic response (Figure 4A; lanes 4
and 6), indicating that hypoxia-induced ATF-4 was mediated by
PHDs. After 24 hours, however, when the hypoxic stabilization of
HIF-1 was still clearly visible, hypoxic ATF-4 induction was no
longer detectable. This transient hypoxia-induced expression of
ATF-4 inversely correlated with the strong hypoxic induction of
PHD3 after 24 hours. In this regard it is interesting to note that we
recently demonstrated that the hypoxic induction of PHD3 corre-
lates with increased hydroxylation activity, which compensates for
decreased oxygen levels.28,29
If PHDs mediated the degradation of ATF-4 in normoxia, the
hypoxia-induced ATF-4 protein should become unstable following
reoxygenation. Therefore, HeLa cells were exposed for 4 hours to
0.2% O2, followed by reoxygenation in the presence of cyclohexi-
mide to inhibit de novo translation. ATF-4 was rapidly degraded
with a half-life (t1/2) of 9 minutes (Figure 4B). However, adding
DMOG at the time of hypoxia resulted in a prolonged ATF-4
protein half-life of 21 minutes.
Because the commercially available anti–ATF-4 antibodies are
of minor quality, the treatment by hypoxia and DMOG was
repeated using HeLa cells transiently transfected with V5-tagged
ATF-4. As shown in Figure 5A, V5–ATF-4 but not V5–ATF-3 or
V5-ARNT could only be detected under hypoxic conditions or after
treatment with DMOG. A cotransfected green fluorescent protein
(GFP) expression vector ensured equal transfection and immuno-
blotting efficiencies.
Identification of an ODD domain in ATF-4
To explore whether the interaction of ATF-4 with PHD3 mediates
hypoxia-inducible stability of ATF-4, we transiently overexpressed
V5-tagged wild-type ATF-4 and various ATF-4 deletion mutants
under normoxic or hypoxic conditions. In contrast to the wild-type
ATF-4, ATF-4 aa 89-181, an ATF-4 variant missing the zipper II
which is responsible for the interaction with PHD3 as described,
plus an adjacent 48-aa domain, was stable in normoxia. Interest-
ingly, deletion of just the 48-aa stretch (ATF-4 aa 133-181)
Figure 3. Hypoxia as well as proteasome and PHD inhibition stabilize ATF-4.
(A) HeLa cells were treated for 8 hours with 300 nM thapsigargin or 10 M MG132.
Subsequently, cells were lysed and analyzed by immunoblotting. (B) HeLa cells were
transiently transfected with an ATF-dependent firefly (FL) luciferase reporter gene
plasmid (pATFx2-Luc) together with the renilla luciferase (RL) control plasmid
pRLSV40. Following exposure to 20% or 1% O2, with or without the addition of 1 mM
DMOG, cells were lysed and luciferase activities were determined. (C) TS-20 cells
(with a temperature-sensitive E1 ubiquitin–activating enzyme defect) and E1-
reconstituted H38–5 cells were exposed to 34°C or 39°C. Subsequently, cells were
lysed and analyzed by immunoblotting. Shown are mean values of the FL/RL ratios
( SD) of 3 independent experiments.
Figure 4. Kinetics of hypoxic stabilization and reoxygenation-induced destabi-
lization of ATF-4. (A) HeLa cells were incubated at 20%, 1%, or 0.2% O2, with or
without the addition of 1 mM DMOG. After 4 or 24 hours, the cells were lysed and
analyzed by immunoblotting. As a control for the induction of ATF-4 by ER stress, one
dish of HeLa cells was treated with 300 nM thapsigargin for 4 hours. (B) HeLa cells
were incubated at 0.2% O2 with or without the addition of 1 mM DMOG. At 4 hours
later, 20 g/mL cycloheximide was added, and cells were reoxygenated at 20% O2.
After the indicated time points, cells were lysed and analyzed by immunoblotting.
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adjacent to the zipper II or an even smaller deletion (ATF-4 aa
154-181) was sufficient to generate increased ATF-4 levels in
normoxia (Figure 5B). Determining the half-life of ATF-4 and
ATF-4 aa 154-181 in reoxygenation, a higher stability of the
ATF-4 aa 154-181 mutant (t1/2, 24 minutes) compared with the
wild-type ATF-4 (t1/2, 13 minutes) was detected (Figure 5C,D).
Since the ATF-4 wt protein seems to be highly instable under
normoxic conditions, we further characterized the identified ODD
in a more sensitive reporter gene assay. Therefore, we determined if
the identified ODD domain of ATF-4 was also sufficient to promote
the degradation of a heterologous protein under normoxia. To this
end, HeLa cells were transiently cotransfected with a Gal-4 driven
firefly luciferase reporter gene plasmid together with expression
vectors containing either Gal-4AD/BD in frame with the HIF-2
ODD aa 404-569 and HIF-2 ODD aa 404-569 with point
mutations of the 2 critical prolines (P405A/P531A), or ATF-4
aa 133-183, and exposed for 24 hours at 20% or 1% O2.
A constitutively active renilla luciferase reporter gene plasmid was
cotransfected for standardization purposes. HeLa cells expressing
the HIF-2 ODD aa 404-569 showed a significant increase in
luciferase activity under hypoxic conditions compared with nor-
moxic conditions, and this effect was abolished by mutation of the
prolines 405 and 531 to alanine (Figure 6A). Similar to the HIF-2
ODD, ATF-4aa 133-183 conferred oxygen-dependent stability to
the heterologous Gal4DB/Gal4AD fusion protein. The critical
ATF-4 domain contains 5 prolyl residues (P156, P162, P164, P167,
and P174). Mutation of all 5 prolines to alanine (V5–ATF-4
5  P 	 A) led to increased ATF-4 levels in normoxia (Figure 6B)
and abolished the destabilizing effect in the Gal4AD/BD ATF-4 aa
133-183 fusion protein (Figure 6A), suggesting that these prolyl
residues define a novel ODD domain within ATF-4. Point mutation
of each proline alone was not sufficient to generate a similar effect
like V5–ATF-4 5  P 	 A (data not shown), indicating a redun-
dant role of each prolyl residue.
Figure 5. ATF-4 aa 154–181 harbors a novel ODD
domain. (A) HeLa cells were transiently transfected with
V5–ATF-4, V5–ATF-3, or V5–ARNT expression vectors.
To control for equal transfection efficiencies, cells were
cotransfected with pEGFPC1. At 6 hours after transfec-
tion, cells were exposed to 1% O2 or treated with 1 mM
DMOG for 24 hours. Subsequently, cells were lysed and
analyzed by immunoblotting. (B) HeLa cells were tran-
siently transfected with different ATF-4 variants and
treated as in panel A. (C) HeLa cells were transiently
transfected with V5–ATF-4 or V5–ATF-4 aa154-181.
To control for equal transfection efficiencies, cells were
cotransfected with pEGFPC1. At 6 hours after transfec-
tion, cells were exposed to 1% O2. After exposure to 1%
O2 for 24 hours, the cells were treated with 20 g/mL
cycloheximide and were reoxygenated with 20% O2.
Cells were lysed at different reoxygenation time points,
and total protein was analyzed by immunoblotting. Band
intensities of 3 independent experiments were deter-
mined and half-life of the V5–ATF-4 and V5–ATF-4
aa154-181 proteins were calculated. (D) Decline of
V5–ATF-4 and V5–ATF-4 aa154-181 after reoxygen-
ation calculated from 3 independently performed experi-
ments as described in panel C. Shown are mean values
( SD) of 3 independent experiments.
Figure 6. The oxygen-dependent stability of ATF-4 is
proline dependent. (A) HeLa cells were transiently trans-
fected with a constitutively expressed renilla luciferase (RL)
control vector, an expression plasmid containing the Gal4
AD/BD (pM3VP16) fused to ATF-4 aa 133–183; ATF-4 aa
133-183, in which prolines P156, P162, P164, P167, and
P174 have been mutated to alanine; HIF-2 aa 404-568; or
HIF-2 aa 404–568 P405/531A together with the Gal4-
driven firefly luciferase (FL) plasmid pGRExE1bLuc. After
transfection cells, were exposed to 20% or 1% O2 for
24 hours, lysed, and analyzed for FL and RL activities.
Shown are mean values plus or minus SD of the FL/RLratios
of 3 independent experiments. (B) HeLa cells were tran-
siently transfected with V5–ATF-4, V5–ATF-4 aa 154-81, or
V5–ATF-4 5 P	 A, in which prolines P156, P162, P164,
P167, and P174 have been mutated to alanine. To control for
equal transfection efficiencies cells were cotransfected with
pEGFPC1. At 6 hours after transfection, cells were exposed
to 20% or 1% O2 for 24 hours. Subsequently, the cells were
lysed and analyzed by immunoblotting. (C) Multiple se-
quence alignment of the proposedATF-4 ODD domain.
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Notably, the normoxic induction of V5–ATF-4 5  P 	 A
was less pronounced than V5–ATF-4 aa 154-181 (Figure 6B).
Despite multiple proline mutations, binding to PHD3 as well as
activation of an ATF-4–dependent reporter gene (pCHOP-AARE-
TK-Luc) was not affected as tested by yeast 2-hybrid analysis
and reporter gene assay (data not shown). Aligning the ATF-4
sequences of mammalian and nonmammalian vertebrate species
indicates that P164, P167, and P174 are highly conserved,
possibly indicating their specific role in regulation of ATF-4
stability (Figure 6C).
PHD3 regulates ATF-4 protein stability
To determine the role of the PHDs in the regulation of ATF-4
protein stability, HeLa cells were transfected with siRNA targeting
PHD2 or PHD3 and exposed to either 20% O2 or 1% O2 for
24 hours. PHD1 was not further investigated, since it was not
detectable at the protein level in HeLa cells (data not shown).
Moreover, in contrast to PHD2 and PHD3, PHD1 expression is not
induced by hypoxia.8 In cells transfected with PHD2 and PHD3
siRNA, an additive up-regulation of HIF-1 in normoxia was
found (Figure 7A). In contrast to HIF-1, ATF-4 protein levels
were up-regulated exclusively by PHD3 silencing but not by PHD2
silencing. As demonstrated here, the hypoxic induction of ATF-4
was transient and not detectable after incubation of HeLa cells for
24 hours at 1% O2. However, after treatment of HeLa cells with
PHD3 siRNA, ATF-4 was up-regulated even after exposing the
cells for 24 hours to hypoxia. PHD3 down-regulation exerted its
effect via increased ATF-4 protein stability as demonstrated in
reoxygenation experiments (Figure 7B). No significant differences
in ATF-4 mRNA levels were found after treatment of HeLa cells
with PHD3 siRNA compared with mock-treated control cells or
after treatment with PHD2 siRNA (Figure 7C). The siRNA
experiments were repeated with independent siRNAs as well as
short hairpin constructs, confirming the previous results (data not
shown). In addition, FIH neither interacted with ATF-4 nor had FIH
siRNA any effect on ATF-4 protein levels (data not shown).
Hydroxylated HIF-1 is strongly bound by pVHL. Thus, we
next determined whether PHD-dependent ATF-4 hydroxylation
leads to subsequent pVHL interaction. Therefore, MBP–ATF-4
or MBP–HIF-2 ODD were treated with HA-PHD2 or His-
PHD3 in the presence of oxygen, 2-oxoglutarate, ferrous iron,
and ascorbic acid. The interaction with His6-Trx–tagged pVHL–
elongin B–elongin C (VBC) complex was examined in a MBP
pull-down assay. However, MBP-HIF-2 ODD but not MBP–
ATF-4 interacted with pVHL following incubation with PHD2
or PHD3 (data not shown).
Discussion
ATF-4, also known as CREB2, TAXREB67, or C/ATF, is a member
of the ATF/CREB family of basic-leucine zipper transcription
factors.30 ATF-4–dependent gene expression has been described for
several genes, including CHOP/GADD153, which is involved in
stress regulatory pathways.31-33 ATF-4 mRNA is present in all
tissues examined thus far, whereas ATF-4 protein levels vary
dependent on a variety of extracellular signals and stress condi-
tions.25 This regulation has been widely attributed to preferential
translation of the ATF-4 mRNA.27 In this work, up-regulation of
ATF-4 protein was found after treatment with hypoxia or the PHD
inhibitor DMOG, demonstrating that mechanisms other than
translational control might be additionally involved in the regula-
tion of ATF-4 protein stability.
Using PHD3 as bait, we identified ATF-4 as a new PHD-
interacting protein. The interaction site was mapped to a leucine
zipper motif of ATF-4, which is also called zipper II. In the
present work, we demonstrate that deletion of aa 154-181, a
region close to the zipper II, results in oxygen-independent
expression of ATF-4. Oxygen-regulated ATF-4 expression was
at least in part dependent on 5 conserved prolyl residues within
this region. Therefore, aa 154-181 of ATF-4 can be considered
as a novel ODD domain.
siRNA experiments strongly suggested a specific role for PHD3
in ATF-4 protein stability. Despite several attempts, we did not
succeed to directly demonstrate ATF-4 hydroxylation by mass
spectrometry or 2-oxoglutarate turnover. Apart from technical
difficulties, the conditions for efficient ATF-4 hydroxylation might
be different from those for HIF-1 hydroxylation. Indeed, major
differences become obvious when the 2 proteins are compared:
first, whereas HIF-1 levels can be regulated by all 3 PHDs, ATF-4
levels are modulated specifically by PHD3; second, HIF-1 is
Figure 7. ATF-4 expression is controlled by PHD3.
(A) HeLa cells were transiently transfected with siRNA
targeting PHD2 or PHD3 and exposed to 20% or 1% O2.
After 24 hours, the cells were lysed and analyzed by
immunoblotting. One dish of HeLa cells was treated for
8 hours with 300 nM thapsigargin (t). Subsequently, cells
were lysed and analyzed together with the protein ex-
tracts of the siRNA-transfected cells. (B) Hela cells were
transiently transfected with siRNA targeting PHD3 or a
control siRNA and exposed to 1% O2 for 4 hours with
subsequent reoxygenation.After the indicated time points,
cells were lysed and analyzed by immunoblotting.
(C) HeLa cells were transiently transfected with siRNA
targeting PHD2 or PHD3 and exposed to 20% or 1% O2.
After 24 hours, the cells were lysed and total RNA was
extracted and analyzed for ATF-4, PHD2, and PHD3
mRNA levels by real-time reverse transcriptase (RT)–
PCR. Shown are mean values plus or minus SD of
3 independent experiments of ratios to the ribosomal
protein L28 mRNAlevels, which were used as housekeep-
ing controls.
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stabilized even under prolonged hypoxia, whereas hypoxic stabili-
zation of ATF-4 is transient and inversely correlates with hypoxic
up-regulation of PHD3; third, as a result of PHD-dependent
modification, HIF-1 but not ATF-4 can be bound to pVHL. This
last finding is consistent with a previous report demonstrating that
oxygen-dependent ATF-4 destruction is independent of pVHL.20
Rather than pVHL, proteasome-dependent degradation of ATF-4
has been demonstrated to rely on the SCFTRCP ubiquitin ligase.34
Further studies will be needed to investigate whether SCF func-
tions as an ATF-4 ubiquitin E3 ligase in an oxygen- and PHD3-
dependent manner. It is, however, still possible that despite
protein-protein interaction, proline residue-dependency, and DMOG
inhibition, PHD3 regulates ATF-4 without direct proline hydroxyla-
tion. Future experiments will show whether PHD3 confers ATF-4
protein stability by recruiting a yet unidentified protein in a
trimolecular complex, which might then be regulated by
hydroxylation.
Of note, PHD3 is the best hypoxia-inducible protein of all
PHDs. We recently observed that PHD3 is still functional even
under 0.2% O2 conditions, albeit at a reduced rate.28 As a
consequence, a protein specifically regulated by PHD3 should only
be transiently stabilized, like we found for ATF-4. Our results thus
provide a possible explanation for the existence of more than one
PHD with similar oxygen affinities: compared with HIF, targets
of only one PHD family member will have different stabilization
kinetics, thereby orchestrating the hypoxic response.
Besides HIF-mediated signal transduction pathways, HIF-
independent pathways have been described to be involved in the
cellular response to low oxygen concentrations using gene
arrays. The molecular mechanisms leading to HIF-independent
hypoxia-inducible mRNA induction remains largely unknown.
Among the HIF-independent oxygen-regulated genes are ATF-4
target genes like CHOP10/GADD153 and ATF-3.35-38 Hypoxia-
inducible regulation of GADD153 has been implicated to play a
role in cell stress response, DNA-repair, and anoxia-induced cell
death.39 Our data provide evidence that in addition to the
translational control of ATF-4 under anoxic conditions, PHD3-
dependent hydroxylation may play a major role in controlling
ATF-4 target gene expression in normoxia and hypoxia. Tight
oxygen-dependent regulation of ATF-4 by PHD3 may be the
molecular basis for the cell fate after exposure to severe
hypoxia. Our data also show that PHD-mediated regulation of
protein levels is not unique for the HIF signal transduction
pathway, suggesting that posttranslational, PHD-mediated modi-
fications are used in additional pathways that need tight and
rapid oxygen-dependent regulation.
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